Month: August 2024

NEWTOWN, Pa., Aug. 2, 2024 /PRNewswire/ — Edelson Lechtzin LLP, a leading class action law firm, announces the filing of a class action lawsuit against CrowdStrike for violations of federal securities laws on behalf of investors of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) common stock…

SANTA ANA, Calif., Aug. 2, 2024 /PRNewswire/ — Consolidated Analytics (CA), a leading provider of comprehensive mortgage services and data analytics, is pleased to announce the successful acquisition of the assets of Investor Claim Solutions (ICS), a well-known firm specializing in…

LOS ANGELES, Aug. 2, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Bolt Biotherapeutics, Inc. (“Bolt” or “the Company”) (NASDAQ: BOLT) for violations of §§10(b) and 20(a) of the Securities…

LOS ANGELES, Aug. 2, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of the securities laws. The…

SILVER SPRING, Md., Aug. 2, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA…

NEW YORK and CHICAGO, Aug. 2, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Methode Electronics, Inc. (“Methode” or the “Company”)…